Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study
Authors not listed
Notal Vision Ltd. · 2007
Abstract
estimate the sensitivity of the HMP test in identifying visual field functional defects in subjects with CNV secondary to AMD
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2007). Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study. <em>Notal Vision Ltd.</em>. https://clinicaltrials.gov/study/NCT00604071
Vancouver
Anonymous. Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study. Notal Vision Ltd.. 2007.
BibTeX
@misc{anon2007Sensit,
title = {Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study},
author = {Anonymous},
journal = {Notal Vision Ltd.},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Notal Vision Ltd. 2009
Open access · US-GOV
Comparison Between Home Macular Perimeter (FORESEE HOME) and OCT Visual Field Defects in Patients With CNV
Notal Vision Ltd. 2009
Open access · US-GOV
Correlation Between Visual Field Defects on Home Macular Perimeter (FORESEE HOME) and on OCT in Eyes of Patients With CNV Before and After Treatment
Springer eBooks 2008
Citation only
Age‐related Macular Degeneration (AMD)
Clinical Interventions in Aging 2006
Open access · OA
Ranibizumab in neovascular age-related macular degeneration
Novartis 2005
Open access · US-GOV
Open-label Multicenter, Phase I/II Study Assessing the Safety and Efficacy of Ranibizumab (RFB002) in Japanese Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
IRCCS San Raffaele 2011
Open access · US-GOV